Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. The company offers innovative solutions to enable commercial-scale cell and gene therapy. Its platform technologies have set new industry standards in automated, integrated manufacturing and testing of complex cellular products such as CAR T cells, TCR-transduced T cells, and gene-modified stem cells. Miltenyi Biotec’s comprehensive product portfolio is complemented with CDMO services for lentiviral vectors and cellular products. The company has more than 3,000 employees in 28 countries and its products have been used in more than 60,000 cell therapy procedures.